Cargando…
Urokinase Receptor (CD87) Regulates Leukocyte Recruitment via β(2) Integrins In Vivo
The urokinase receptor (CD87; uPAR) is found in close association with β(2) integrins on leukocytes. We studied the functional consequence of this association for leukocyte adhesion and migration. In vivo, the β(2) integrin–dependent recruitment of leukocytes to the inflamed peritoneum of uPAR-defic...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212528/ https://www.ncbi.nlm.nih.gov/pubmed/9743521 |
Sumario: | The urokinase receptor (CD87; uPAR) is found in close association with β(2) integrins on leukocytes. We studied the functional consequence of this association for leukocyte adhesion and migration. In vivo, the β(2) integrin–dependent recruitment of leukocytes to the inflamed peritoneum of uPAR-deficient mice was significantly reduced as compared with wild-type animals. In vitro, β(2) integrin–mediated adhesion of leukocytes to endothelium was lost upon removal of uPAR from the leukocyte surface by phosphatidyl-inositol–specific phospholipase C. Leukocyte adhesion was reconstituted when soluble intact uPAR, but not a truncated form lacking the uPA-binding domain, was allowed to reassociate with the cell surface. uPAR ligation with a monoclonal antibody induced adhesion of monocytic cells and neutrophils to vascular endothelium by six- to eightfold, whereas ligation with inactivated uPA significantly reduced cell-to-cell adhesion irrespective of the β(2) integrin–stimulating pathway. These data indicate that β(2) integrin–mediated leukocyte–endothelial cell interactions and recruitment to inflamed areas require the presence of uPAR and define a new phenotype for uPAR-deficient mice. Moreover, uPAR ligation differentially modulates leukocyte adhesion to endothelium and provides novel targets for therapeutic strategies in inflammation-related vascular pathologies. |
---|